Although germline mutations in MSH2, MLH1, MSH6, or PMS2 only account for 2% of hereditary ovarian cancer, the loss of function of these genes by other mechanisms accounts for at least 29% of ovarian cancer cases. This evidence concerns the gene MLH1 and ovarian cancer.